Comparative Analysis of Phase Lag Entropy (PLE) and Bispectral Index (BIS) as an Anesthetic Depth Indicator

February 5, 2018 updated by: Kyung Mi Kim, Hallym University Medical Center

Comparative Analysis of Phase Lag Entropy (PLE) and Bispectral Index (BIS) as an Anesthetic Depth Indicator in Patients Undergoing Otopharyngeal Surgery With Facial Nerve Integrity Monitoring

The aim of this comparative analysis is to evaluate the reliability of PLE value as an anesthetic depth indicator

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

  1. To evaluate the reliability of PLE value as an anesthetic depth indicator, the investigators compare PLE value with BIS score during induction and emergence of general anesthesia using propofol target controlled infusion.
  2. In addition, the investigators verify whether or not the facial nerve integrity monitoring affects the efficacy for PLE and BIS values as an anesthetic depth indicator.

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeonggi-do
      • Anyang-si, Gyeonggi-do, Korea, Republic of
        • Recruiting
        • Hallym University Medical Center
        • Contact:
          • Kyung Mi Kim, Ph.D.
          • Phone Number: 82313803945
        • Principal Investigator:
          • Kyung Mi Kim, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who scheduled for otopharyngeal surgery under facial nerve integrity monitoring requiring general anesthesia and American Society of Anesthesiology (ASA) physical status 1 or 2

Exclusion Criteria:

  • Patient who has been taken anticonvulsant agents, sedatives, and hypnotics
  • Patient who has central nerve system disease, neurological disorder
  • Patient with hypersensitivity to anesthetics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Comparison of PLE and BIS
Investigators assess PLE and BIS values as indicators of the depth of anesthesia during induction and emergence of anesthesia and facial nerve integrity monitoring
Investigators attach the PLE and BIS sensors on the forehead of the patients undergoing facial nerve integrity monitoring during general anesthesia using total intravenous anesthetics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PLE value during induction and emergence of general anesthesia
Time Frame: Through study completion, an average of fifteen months

Investigators measure the PLE value as an anesthetic depth indicator before the injection of propofol, at the time point of no response to verbal command, before and after intubation, and at the time point of response to verbal command during emergence of anesthesia.

The PLE value will be reported in a score ranging from 0 (burst suppression or deep sedated) to 100 (full awake).

Through study completion, an average of fifteen months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BIS value during induction and emergence of general anesthesia
Time Frame: Through study completion, an average of fifteen months

Investigators measure the BIS value as an anesthetic depth indicator before the injection of propofol, at the time point of no response to verbal command, before and after intubation, and at the time point of response to verbal command during emergence of anesthesia.

The BIS value will be reported in a score ranging from 0 (burst suppression or deep sedated) to 100 (full awake).

Through study completion, an average of fifteen months
PLE value during facial nerve integrity monitoring
Time Frame: Through study completion, an average of fifteen months

Investigators measure the PLE value at the time points of facial nerve integrity monitoring.

The PLE value will be reported in a score ranging from 0 (burst suppression or deep sedated) to 100 (full awake).

Through study completion, an average of fifteen months
BIS value during facial nerve integrity monitoring
Time Frame: Through study completion, an average of fifteen months

Investigators measure the BIS value at the time points of facial nerve integrity monitoring.

The BIS value will be reported in a score ranging from 0 (burst suppression or deep sedated) to 100 (full awake).

Through study completion, an average of fifteen months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kyung Mi Kim, Ph.D., Department of Anesthesiology and Pain Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2017

Primary Completion (Anticipated)

October 31, 2018

Study Completion (Anticipated)

October 31, 2018

Study Registration Dates

First Submitted

January 17, 2018

First Submitted That Met QC Criteria

February 5, 2018

First Posted (Actual)

February 7, 2018

Study Record Updates

Last Update Posted (Actual)

February 7, 2018

Last Update Submitted That Met QC Criteria

February 5, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 3-2017-10047988

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Anesthesia

Clinical Trials on PLE and BIS

Subscribe